[Neisseria meningitidis strains with decreased susceptibility to penicillin and ampicillin]

J L Quiles Durá1, C Rico Urios, E Climent Forner

  • 1Servicio de Pediatría, Hospital General Universitario de Elche.

Insights

Meningococcal infection strains B and C show moderate penicillin resistance, especially strain C. Ceftriaxone is recommended over penicillin for treating these infections due to emerging resistance concerns.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Meningococcal infections, including sepsis and meningitis, pose significant public health challenges.
  • Antibiotic resistance in Neisseria meningitidis strains can complicate treatment strategies.

Purpose of the Study:

  • To investigate the antibiotic susceptibility patterns of Neisseria meningitidis strains isolated from patients with meningococcal infections.
  • To evaluate the effectiveness of current antibiotic treatments and recommend optimal therapeutic options.

Main Methods:

  • Retrospective analysis of 38 patients (31 children, 7 adults) diagnosed with meningococcal infection.
  • Isolation and antimicrobial susceptibility testing of Neisseria meningitidis strains, focusing on penicillin, ceftriaxone, and chloramphenicol.
  • Clinical outcome assessment for patients treated with penicillin G.

Main Results:

  • Neisseria meningitidis serogroup B was the most frequent isolate (44.7%), followed by serogroup C (31.6%).
  • Over half (52.6%) of the isolated strains exhibited moderate penicillin resistance, with 91.6% of serogroup C strains showing this resistance.
  • No resistance was observed against ceftriaxone or chloramphenicol.

Conclusions:

  • Moderate penicillin resistance in meningococcal strains, particularly serogroup C, necessitates careful treatment selection.
  • While penicillin G was effective in this cohort, emerging resistance and potential beta-lactamase production support ceftriaxone as the preferred empirical treatment.
  • Antimicrobial susceptibility testing (antibiogram) is crucial for guiding precise treatment decisions in meningococcal infections.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...